The folate receptor (FR) has been found to be a promising tumor marker and a target for several novel therapeutic approaches in laboratory and in pre-clinical and clinical trials. The applicant's laboratory has contributed substantially to the identification of multiple tissue specific isoforms of the FR and studies of their structure, function, and differential regulation in various malignancies including the establishment of FR type beta as a myeloid differentiation marker and a potential marker for certain myeloid leukemias. The gene structures and the basal promoters for the FR isoforms have been characterized by the applicant's and other laboratories. Preliminary studies show that FR beta is specifically and strikingly upregulated in myeloid leukemia cells by retinoic acid, independent of differentiation. Preliminary studies also indicate that large differences in FR alpha mRNA levels among carcinoma cells occur post-transcriptionally. The applicant proposes to study molecular mechanisms underlying critical regulatory processes in FR expression by (i) identification of putative novel regulatory elements in the FR alpha, beta, and gamma genes that confer their narrow tissue and tumor specificity; (ii) characterization of upstream and downstream molecular events in differentiation- independent retinoid-induced modulation of the FR beta gene in myeloid leukemia cells; and (iii) elucidation of the post-transcriptional mechanisms responsible for the variable expression of FR-alpha among carcinoma cells. All of the above studies with cell lines will be extended to malignant situations in vivo. The proposed studies will resolve key issues of clinical significance in FR regulation and will investigate a promising novel strategy to treat myeloid leukemias refractory to retinoid differentiation therapy. They further promise to reveal novel mechanisms of tissue/tumor specific gene regulation with potential applications in the broad context of future gene therapy strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA080183-01
Application #
2747773
Study Section
Special Emphasis Panel (ZRG2-ET-2 (01))
Program Officer
Marks, Cheryl L
Project Start
1998-12-01
Project End
2002-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Toledo
Department
Biochemistry
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Zhang, J; Gonit, M; Salazar, M D et al. (2010) C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction. Oncogene 29:723-38
Sivakumaran, Suneethi; Zhang, Juan; Kelley, Karen M M et al. (2010) Androgen activation of the folate receptor ? gene through partial tethering of the androgen receptor by C/EBP?. J Steroid Biochem Mol Biol 122:333-40
Li, Hong; Lu, Yanhui; Piao, Longzhu et al. (2010) Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid. Int J Pharm 402:57-63
van der Heijden, Joost W; Oerlemans, Ruud; Dijkmans, Ben A C et al. (2009) Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum 60:12-21
Hao, H; d'Alincourt-Salazar, M; Kelley, K M M et al. (2007) Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen. Oncogene 26:7872-84
Blaser, B W; Gonit, M; Qi, H et al. (2007) Induction of folate receptor type beta in a bone marrow engraftment model of acute myelogenous leukemia. Leukemia 21:2233-5
Salazar, Marcela D'Alincourt; Ratnam, Manohar (2007) The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev 26:141-52
Qi, Huiling; Ratnam, Manohar (2006) Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. Cancer Res 66:5875-82
Tran, Thuyet; Shatnawi, Aymen; Zheng, Xuan et al. (2005) Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. Cancer Res 65:4431-41
Elnakat, Hala; Ratnam, Manohar (2004) Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev 56:1067-84

Showing the most recent 10 out of 17 publications